Status:

COMPLETED

A Pharmacokinetic Evaluation of Metformin in Relation to the Polymorphism A270S in Healthy Caucasian Volunteers

Lead Sponsor:

University of Southern Denmark

Conditions:

Metformin

Organic Cation Transporter 2

Eligibility:

All Genders

18-65 years

Phase:

PHASE4

Brief Summary

The aim of the study is to evaluate the pharmacokinetics of metformin in healthy Caucasians volunteers with and without the polymorphism A270S in OCT2,thus the study hypothesis is that renal clearance...

Eligibility Criteria

Inclusion

  • Healthy volunteers
  • Written consent
  • rs316019 genotyped
  • Age 18-65 years old

Exclusion

  • Daily medication
  • Alcohol abuse
  • Pregnancy
  • Breastfeeding

Key Trial Info

Start Date :

August 1 2010

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2010

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT01237522

Start Date

August 1 2010

End Date

December 1 2010

Last Update

December 29 2010

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Institute of Public Health, Clinical Pharmacology, University of Southern Denmark

Odense, Denmark, 5000